Multicenter Epidemiologic Study on Hepatocellular Carcinoma in Turkey |
Can, Alper
(Department of Medical Oncology, Faculty of Medicine, Van Yuzuncu Yil University)
Dogan, Erkan (Department of Medical Oncology, Faculty of Medicine, Van Yuzuncu Yil University) Bayoglu, Ibrahim Vedat (Department of Medical Oncology, Faculty of Medicine, Katip Celebi University) Tatli, Ali Murat (Department of Medical Oncology, Regional Training and Research Hospital) Besiroglu, Mehmet (Department of Medical Oncology, Faculty of Medicine Marmara University) Kocer, Murat (Department of Medical Oncology, Faculty of Medicine Sulayman Demirel University) Dulger, Ahmet Cumhur (Department of Medical Oncology, Faculty of Medicine, Van Yuzuncu Yil University) Uyeturk, Ummugul (Department of Medical Oncology, Faculty of Medicine, Izzet Baysal University) Kivrak, Derya (Department of Medical Oncology, Faculty of Medicine, Akdeniz University) Orakci, Zuat (Department of Medical Oncology, Faculty of Medicine Dicle University) Bal, Oznur (Department of Medical Oncology, Regional Training and Research Hospital) Kacan, Turgut (Department of Medical Oncology, Faculty of Medicine Cumhuriyet University) Olmez, Sehmus (Department of Medical Oncology, Faculty of Medicine, Van Yuzuncu Yil University) Turan, Nedim (Department of Medical Oncology, Regional Training and Research Hospital) Ozbay, Mehmet Fatih (Department of Medical Oncology, Regional Training and Research Hospital) Alacacioglu, Ahmet (Department of Medical Oncology, Faculty of Medicine, Katip Celebi University) |
1 | Turkey Liver Research Association National Hepatitis Often Study (TURKHEP 2010). |
2 | Zidan A, Scheuerlein H, Schule S, et al (2012). Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in Iran and wordwide. Hepat Mon, 12, 14-22. |
3 | Wang BE, Ma WM, Sulaiman A, et al (2002). Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries. J Med Virol, 67, 394-400. DOI ScienceOn |
4 | Stuart KE, Anand AJ, Jenkins RL (1996). Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer, 77, 2217-22. DOI |
5 | Su CH, Lin Y, Cai L (2013). enetic factors, viral infection, other factors and liver cancer: an update on current progress. Asian Pac J Cancer Prev, 14, 49053-60. |
6 | Yaprak O, Akyildiz M, Dayangac M, et al (2012). AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int, 11, 256-61. DOI ScienceOn |
7 | Uzunalimoglu O, Yurdaydin C, Cetinkaya H, et al (2001). Risk factors for hepatocellular carcinoma in Turkey. Dig Dis Sci, 46, 1022-8. DOI ScienceOn |
8 | Xu J, Liu C, Zhou L, et al (2012). Distinctions between clinicopathological factors and prognosis of alphafetoprotein negative and positive hepatocellular carcinoma patients. Asian Pac J Cancer Prev, 13, 559-62. DOI ScienceOn |
9 | Yalcin K, Yakut M, Degertekin H, et al (2013). Clinical and epidemiological characteristics of hepatocellular carsinoma cases in East and Southeastern Region of Turkey. Clin J Med, 33, 806-13. |
10 | Yeo Y, Gwack J, Kang S, et al (2013). Viral hepatitis and liver cancer in Korea: an epidemiological perspective. Asian Pac J Cancer Prev, 14, 6227-31. DOI ScienceOn |
11 | Zhang BH, Yang BH, Tang ZY (2004). Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol, 130, 417-22. |
12 | Monto A, Wright TL (2001). The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol, 28, 441-9. DOI ScienceOn |
13 | Lim HY, Sohn I, Deng S, et al (2013). Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Ann Surg Oncol, 20, 3747-53. DOI ScienceOn |
14 | Markovic S, Gadzijev E, Stabuc B, et al (1998). Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients. J Hepatol, 29, 650-9. DOI ScienceOn |
15 | Marrero CR, Marrero JA (2007). Viral hepatitis and hepatocellular carcinoma. Arch Med Res, 38, 612-20. DOI ScienceOn |
16 | Norsa'adah B, Nurhazalini-Zayani CG (2013). Epidemiology and survival of hepatocellular carcinoma in north-east peninsular Malaysia. Asian Pac J Cancer Prev, 14, 6955-9. DOI ScienceOn |
17 | Schoniger-Hekele M, Muller C, Kutilek M, et al (2001). Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut, 48, 103-9. DOI |
18 | Ozer B, Serin E, Yilmaz U, et el (2003). Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey. Turk J Gastroenterol, 14, 85-90. |
19 | Purtilo DT, Kersey JH, Hallgren HM, et al (1973). Alphafetoprotein: diagnostic and prognostic use in patients with hepatomas. Am J Clin Pathol, 59, 295-9. |
20 | Sakar B, Ustuner Z, Karagol H, et al (2004). Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis. Am J Clin Oncol, 27, 489-93. DOI ScienceOn |
21 | Stroffolini T, Andreone P, Andriulli A, et al (1998). Characteristics of hepatocellular carcinoma in Italy. J Hepatol, 29, 944-52. DOI ScienceOn |
22 | Fong Y, Sun RL, Jarnagin W, et al (1999). An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg, 229, 790-800. DOI ScienceOn |
23 | Bruix J, Sherman M (2005). Menagement of hepatocellular carcinoma. An update. AASLD Practice Guidelines. |
24 | Chang HC, Lin YM, Yen AMF, et al (2013). Predictors of longterm survival in hepatocellular carcinomas: a longitudinal follow-up of 108 patients with small tumors. Anticancer Res, 33, 5171-8 |
25 | Dogan E, Yalcin S, Koca D, et al (2012). Clinicopathological characteristics of hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev, 13, 2985-90. DOI ScienceOn |
26 | Geramizadeh B, Asadi N, Tabei SZ (2012). Cytologic comparison between malignant and regenerative nodules in the background of cirrhosis. Hepat Mon, 12, 448-52 DOI ScienceOn |
27 | Lee CH, Hsieh SY, Lin JL et al (2013). Hepatocellular carcinoma in patients with chronic kidney disease. World J Gastroenterol ,19, 2466-72. DOI ScienceOn |
28 | Hassan MM, Hwang LY, Hatten CJ, et al (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology, 36, 1206-13. DOI ScienceOn |
29 | Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol, 24, 2137-50. DOI ScienceOn |
30 | Lee FI (1966). Cirrhosis and hepatoma in alcoholics. Gut, 7, 77-85. DOI |
31 | Lehman EM, Wilson ML (2009). Epidemiology of hepatitis viruses among hepatocellular car cinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer, 124, 690-7. DOI ScienceOn |
32 | Bosch FX, Ribes J, Borras J (1999). Epidemiology of primary liver cancer. Semin Liver Dis, 19, 271-85. DOI ScienceOn |
33 | Alacacioglu A, Somali I, Simsek I, et al (2008). Epidemiology and survival of hepatocellular carcinoma in Turkey: outcome of multicenter study. Jpn J Clin Oncol, 38, 683-8. DOI ScienceOn |
34 | Borzio M, Colloredo G, Pioltelli P, et al (2007). Epidemiology and outcome of hepatocellular carcinoma in Lombardy. Dig Liver Dis, 39, 1011-7. DOI ScienceOn |
35 | Beasley RP, Hwang LY, Lin CC, et al (1981). Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet, 21, 1129-33. |